欢迎您！东篱公司
退出
-
申报数据库
-
立项数据库
-
成果数据库
-
项目获奖数据库
中文摘要：
胰腺癌具有起病隐匿、早期侵袭性生长和远处转移的特性，外科手术切除是治愈胰腺癌的唯一机会。由于胰腺癌的特性，临床发现时多为中晚期，大多数患者已经丧失手术切除机会。对于这类患者，如何预测其预后，为提高患者生存期、生存质量制订相关治疗策略，成为胰腺癌临床工作的重点、难点。为此，临床上采用多种方式对胰腺癌患者进行病情评估，预测其预后。本文就肿瘤标志物CA19—9水平在胰腺癌患者预后判断上的应用进展做一综述。
英文摘要：
Pancreatic cancer has the characters of onste delitescence, invasive growth in early stage and other organ metastasis. Surgical resection is the only curing chance, due to these characters, most patients with pancreatic cancer already lose the opportunity receiving surgery ectomy when they were first diagnosed as middle or high stage of pancreatic cancer, for these patients, it＇s a hot point in clinical work to estimate their prognosis, improve the span of their life and make strategies improving their quality of life. Many estimation ways are used to achieve this goal in clinical work. This paper review the serum level of tumor marker CA 19-9 in the prognosis estimation of patients with pancreatic cancer.
同期刊论文项目
同项目期刊论文
期刊信息
位置：